Try it
Pharmacology · Sex hormone drugs: GnRH agonist flare
Sample itemA 68-year-old man with metastatic prostate cancer involving the lumbar spine is about to start leuprolide. Which precaution prevents a harmful early event, and why?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Start an antiandrogen such as bicalutamide before and with leuprolide, to block the initial testosterone surge
A GnRH agonist initially stimulates LH release and causes a transient rise in testosterone for one to two weeks before pituitary desensitisation lowers it. In metastatic disease this flare can worsen bone pain, urinary obstruction or cord compression. An antiandrogen started a week before and continued for some weeks blocks the receptor effect.
Option by option
A. Give a 5-alpha reductase inhibitor to prevent bone pain
A 5-alpha reductase inhibitor does not prevent the flare in metastatic disease and is not part of this protocol.
B. Give leuprolide with testosterone to prevent hypogonadism
Giving testosterone would feed the tumour and worsen the disease.
C. Start a GnRH antagonist and a GnRH agonist together
Combining agonists and antagonists is not the standard flare precaution; antagonists such as degarelix act without a surge alone.
D. Start an antiandrogen such as bicalutamide before and with leuprolide, to block the initial testosterone surge (correct)
An antiandrogen blocks androgen receptors during the early testosterone surge.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?